Medicines Australia Chair, Dr Anna Lavelle, has been appointed a Member of the Order of Australia (AM) for her significant service to science and innovation.

Dr Lavelle was named in the King’s Birthday Honours Roll in June and attended the investiture held in Melbourne on Thursday 14 September.

Over the course of her career, Dr Lavelle has contributed significantly to Australia’s medicines, research and biotechnology industries. She has been a pioneer for women in these industries, holding executive and board positions and driving innovation for the benefit of society for more than 25 years.

“Dr Lavelle has been fearless leader throughout her career, combining her extensive understanding of Australia’s medicines and biotechnology policies with deep experience in medical research. Her unwavering commitment to improving patient outcomes and quality of life is resolute,” Medicines Australia CEO Liz de Somer said. 

“Medicines Australia is extremely fortunate to have Dr Lavelle as our Chair and on behalf of the pharmaceutical industry, we congratulate Dr Lavelle on this prestigious and most deserved achievement.”